DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8qv9jc/investigation) has announced the addition of the "Investigation Report on China's Metformin Market, 2010-2019" report to their offering.
According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million in the world, 80% of which come from middle income and low income countries and the figure demonstrates a fast rising trend. It is estimated that by 2035, there will be nearly 592 million people suffering from diabetes in the whole world. The number of diabetes patients in China was estimated to be 98.4 million in 2013, ranking first in the world, followed by India (65.1 million), USA (24.4 million), Brazil (11.9 million) and Russia (10.9 million). IDF estimates that by 2035, the number of diabetes patients in China will reach 143 million, still ranking first in the world while in America it will reach 29.7 million. The fast growth of diabetes in China and other developing countries has put a heavy burden on their social and economic development.
There are about 90 million diabetes patients in today's China and 95% of them suffer from type 2 diabetes mellitus. And the number of potential patients might reach up to 200 million.
According to this market survey, metformin has kept growing after entering China in 1999, sales value in sample hospitals being about CNY 350 million in 2014 and CAGR during the period of 2005-2014 reaching 16%.
Currently, products of Sino-American Shanghai Squibb occupy about 80% of the metformin market in China while the rest of the market share is taken up by such companies as Liling and Hebei Ideal & Hightech Pharmaceutical Co., Ltd.
Key Topics Covered:
1 Related Concepts of Metformin
2 Market Profile of Metformin in China
3 Survey on Sales Status of Metformin in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Metformin in China, 2010-2014
5 Survey on Dosage Forms of Metformin in China, 2010-2014
6 Reference Price of Metformin in Chinese Hospitals in 2014
7 Major Manufacturers of Metformin in Chinese Market, 2010-2014
8 Market Outlook of Metformin in China, 2015-2019
- Sino-American Shanghai Squibb Pharmaceuticals, Ltd
- Bristol-Myers Squibb
- Beijing Liling-hengtai Pharmaceutical Co., Ltd
- Hebei Ideal & Hightech Pharmaceutical Co., Ltd
- Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd
- Beijing Shengyong Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/8qv9jc/investigation